相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Existential Psychotherapy for Patients With Advanced Cancer: Facing the Future and the Past
David Spiegel
JOURNAL OF CLINICAL ONCOLOGY (2015)
Meaning-Centered Group Psychotherapy: An Effective Intervention for Improving Psychological Well-Being in Patients With Advanced Cancer
William Breitbart et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Psilocybin, psychological distress, and suicidality
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Efficacy and Safety of Quetiapine-XR as Monotherapy or Adjunctive Therapy to a Mood Stabilizer in Acute Bipolar Depression With Generalized Anxiety Disorder and Other Comorbidities: A Randomized, Placebo-Controlled Trial
Keming Gao et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review
Luigi Grassi et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2014)
Treatment of depression in adults with cancer: a systematic review of randomized controlled trials
J. Walker et al.
PSYCHOLOGICAL MEDICINE (2014)
Association of Depression and Anxiety on Quality of Life, Treatment Adherence, and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
Oscar Arrieta et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Effects of Psycho-Oncologic Interventions on Emotional Distress and Quality of Life in Adult Patients With Cancer: Systematic Review and Meta-Analysis
Hermann Faller et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Distress Management Clinical Practice Guidelines in Oncology
Jimmie C. Holland et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
Matthew W. Johnson et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
SUICIDALITY AND ITS ASSOCIATED FACTORS IN CANCER PATIENTS: RESULTS OF A MULTI-CENTER STUDY IN KOREA
Eun-Jung Shim et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean et al.
JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Erich Studerus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
Alex J. Mitchell et al.
LANCET ONCOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder
Louis S. Matza et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Depression and cancer mortality: a meta-analysis
M. Pinquart et al.
PSYCHOLOGICAL MEDICINE (2010)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Religious coping methods as predictors of psychological, physical and spiritual outcomes among medically ill elderly patients: A two-year longitudinal study
KI Pargament et al.
JOURNAL OF HEALTH PSYCHOLOGY (2004)
Measuring spiritual well-being in people with cancer: The functional assessment of chronic illness therapy-spiritual well-being scale (FACIT-Sp)
AH Peterman et al.
ANNALS OF BEHAVIORAL MEDICINE (2002)
Psychiatric morbidity and impact on hospital length of stay among Hematologic cancer patients receiving stem-cell transplantation
JM Prieto et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Depression and degree of acceptance of adjuvant cytotoxic drugs
M Colleoni et al.
LANCET (2000)
Anxiety and depression in cancer patients:: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire
J Skarstein et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2000)
分享论文
